Endothelial Damage, Asymmetric Dimethylarginine and Cardiovascular Risk in End-Stage Renal Disease

Publisher： Karger

E-ISSN： 1421-9735|20|5|469-472

ISSN： 0253-5068

Source： Blood Purification, Vol.20, Iss.5, 2002-08, pp. : 469-472

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxidative Balance Score and the Risk of End-Stage Renal Disease and Cardiovascular Disease

By  

American Journal of Nephrology, Vol. 45, Iss. 4, 2017-03 ,pp. : 338-345

Karger

Access to resources Recommend Favorite

Relationship between Salt Intake, Nitric Oxide and Asymmetric Dimethylarginine and Its Relevance to Patients with End-Stage Renal Disease

By  

Blood Purification, Vol. 20, Iss. 5, 2002-08 ,pp. : 466-468

Karger

Access to resources Recommend Favorite

Nocturnal Hypoxemia: A Neglected Cardiovascular Risk Factor in End-Stage Renal Disease?

By  

Blood Purification, Vol. 20, Iss. 1, 2002-01 ,pp. : 120-123

Karger

Access to resources Recommend Favorite

Circulating Endothelial Progenitor Cell Levels Predict Cardiovascular Events in End-Stage Renal Disease Patients on Maintenance Hemodialysis

By  

Nephron, Vol. 130, Iss. 3, 2015-06 ,pp. : 151-158

Karger

Access to resources Recommend Favorite

Gender-Dependent Impact of Risk Factors for Cardiovascular and Non-Cardiovascular Mortality in End-Stage Renal Disease Patients on Haemodialysis

By  

Kidney and Blood Pressure Research, Vol. 31, Iss. 5, 2008-11 ,pp. : 360-366

Karger

Access to resources Recommend Favorite